↓ Skip to main content

Cochrane Database of Systematic Reviews

Sulpiride versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
162 Mendeley
Title
Sulpiride versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, April 2014
DOI 10.1002/14651858.cd007811.pub2
Pubmed ID
Authors

Jijun Wang, Stephanie Sampson

Abstract

Sulpiride is a relatively old antipsychotic drug reputed to have a low incidence of adverse effects and an effect on the negative symptoms of schizophrenia. This relatively inexpensive antipsychotic drug has a similar neuropharmacological profile to several novel atypical drugs.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 160 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 16%
Student > Ph. D. Student 19 12%
Student > Bachelor 19 12%
Researcher 17 10%
Student > Doctoral Student 11 7%
Other 25 15%
Unknown 45 28%
Readers by discipline Count As %
Medicine and Dentistry 39 24%
Psychology 22 14%
Nursing and Health Professions 19 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Social Sciences 7 4%
Other 16 10%
Unknown 51 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2019.
All research outputs
#4,785,647
of 23,133,982 outputs
Outputs from Cochrane database of systematic reviews
#7,165
of 12,377 outputs
Outputs of similar age
#47,476
of 227,816 outputs
Outputs of similar age from Cochrane database of systematic reviews
#143
of 236 outputs
Altmetric has tracked 23,133,982 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,377 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.4. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,816 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.